TNF-α is an independent serum marker for proliferative retinopathy in type 1 diabetic patients

Journal of Diabetes and its Complications

Volumn 22, Issue 5, 2008, Pages 309-316

  Gustavsson, Carin ^a   Agardh, Elisabet ^a   Bengtsson, Boel ^a   Agardh, Carl David ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adhesion molecules; Cytokines; Diabetic retinopathy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BIOLOGICAL MARKER; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; PADGEM PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIABETIC HYPERTENSION; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; ONSET AGE; OPHTHALMOSCOPY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RANK SUM TEST; STEREO FUNDUS PHOTOGRAPHY;

ADULT; AGED; BIOLOGICAL MARKERS; CELL PROLIFERATION; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MIDDLE AGED; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 42549108719     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2007.03.001     Document Type: Article

References (44)

1. Abu el Asrar A.M., Maimone D., Morse P.H., Gregory S., and Reder A.T. Cytokines in the vitreous of patients with proliferative diabetic retinopathy. American Journal of Ophthalmology 114 (1992) 731-736
2. Adamis A.P. Is diabetic retinopathy an inflammatory disease?. British Journal of Ophthalmology 86 (2002) 363-365
3. Araszkiewicz A., Zozulinska D.A., Trepinska M.M., and Wierusz-Wysocka B. Inflammatory markers as risk factors for microangiopathy in type 1 diabetic patients on functional intensive insulin therapy from the onset of the disease. Diabetes Research and Clinical Practice 74 (2006) S34-S40
4. Barouch F.C., Miyamoto K., Allport J.R., Fujita K., Bursell S.E., Aiello L.P., Luscinskas F.W., and Adamis A.P. Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. Investigative Ophthalmology & Visual Science 41 (2000) 1153-1158
5. Ben-Mahmud B.M., Mann G.E., Datti A., Orlacchio A., Kohner E.M., and Chibber R. Tumor necrosis factor-alpha in diabetic plasma increases the activity of core 2 GlcNAc-T and adherence of human leukocytes to retinal endothelial cells: Significance of core 2 GlcNAc-T in diabetic retinopathy. Diabetes 53 (2004) 2968-2976
6. Ben-Mahmud B.M., Chan W.H., Abdulahad R.M., Datti A., Orlacchio A., Kohner E.M., and Chibber R. Clinical validation of a link between TNF-alpha and the glycosylation enzyme core 2 GlcNAc-T and the relationship of this link to diabetic retinopathy. Diabetologia 49 (2006) 2185-2191
7. Bhavsar A.R. Diabetic retinopathy: The latest in current management. Retina 26 (2006) S71-S79
8. Blankenberg S., Barbaux S., and Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 170 (2003) 191-203
9. Chibber R., Ben-Mahmud B.M., Mann G.E., Zhang J.J., and Kohner E.M. Protein kinase C beta2-dependent phosphorylation of core 2 GlcNAc-T promotes leukocyte-endothelial cell adhesion: A mechanism underlying capillary occlusion in diabetic retinopathy. Diabetes 52 (2003) 1519-1527
10. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. New England Journal of Medicine 329 (1993) 977-986
11. Dinarello C.A. Interleukin-1beta. Critical Care Medicine 33 (2005) S460-S462
12. Doganay S., Evereklioglu C., Er H., Turkoz Y., Sevinc A., Mehmet N., and Savli H. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. Eye 16 (2002) 163-170
13. ETDRS group. Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 98 (1991) 786-806
14. EURODIAB. Microvascular and acute complications in IDDM patients: The EURODIAB IDDM Complications Study. Diabetologia 37 (1994) 278-285
15. Fasching P., Veitl M., Rohac M., Streli C., Schneider B., Waldhausl W., and Wagner O.F. Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 81 (1996) 4313-4317
16. Franks W.A., Limb G.A., Stanford M.R., Ogilvie J., Wolstencroft R.A., Chignell A.H., and Dumonde D.C. Cytokines in human intraocular inflammation. Current Eye Research 11 Suppl. (1992) 187-191
17. Funatsu H., Yamashita H., Noma H., Mimura T., Yamashita T., and Hori S. Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema. American Journal of Ophthalmology 133 (2002) 70-77
18. Hatchell D.L., Wilson C.A., and Saloupis P. Neutrophils plug capillaries in acute experimental retinal ischemia. Microvascular Research 47 (1994) 344-354
19. Hernandez C., Burgos R., Canton A., Garcia-Arumi J., Segura R.M., and Simo R. Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: A case-control study. Diabetes Care 24 (2001) 516-521
20. Hernandez C., Segura R.M., Fonollosa A., Carrasco E., Francisco G., and Simo R. Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy. Diabetic Medicine 22 (2005) 719-722
21. Joussen A.M., Poulaki V., Qin W., Kirchhof B., Mitsiades N., Wiegand S.J., Rudge J., Yancopoulos G.D., and Adamis A.P. Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. American Journal of Pathology 160 (2002) 501-509
22. Joussen A.M., Poulaki V., Mitsiades N., Kirchhof B., Koizumi K., Dohmen S., and Adamis A.P. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. FASEB Journal 16 (2002) 438-440
23. Joussen A.M., Poulaki V., Le M.L., Koizumi K., Esser C., Janicki H., Schraermeyer U., Kociok N., Fauser S., Kirchhof B., Kern T.S., and Adamis A.P. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB Journal 18 (2004) 1450-1452
24. Kauffmann D.J., van Meurs J.C., Mertens D.A., Peperkamp E., Master C., and Gerritsen M.E. Cytokines in vitreous humor: Interleukin-6 is elevated in proliferative vitreoretinopathy. Investigative Ophthalmology & Visual Science 35 (1994) 900-906
25. Kojima S., Yamada T., and Tamai M. Quantitative analysis of interleukin-6 in vitreous from patients with proliferative vitreoretinal diseases. Japanese Journal of Ophthalmology 45 (2001) 40-45
26. Kowluru R.A., and Odenbach S. Role of interleukin-1beta in the pathogenesis of diabetic retinopathy. British Journal of Ophthalmology 88 (2004) 1343-1347
27. Limb G.A., Hickman-Casey J., Hollifield R.D., and Chignell A.H. Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy. Investigative Ophthalmology & Visual Science 40 (1999) 2453-2457
28. Matsumoto K., Sera Y., Ueki Y., Inukai G., Niiro E., and Miyake S. Comparison of serum concentrations of soluble adhesion molecules in diabetic microangiopathy and macroangiopathy. Diabetic Medicine 19 (2002) 822-826
29. McLeod D.S., Lefer D.J., Merges C., and Lutty G.A. Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. American Journal of Pathology 147 (1995) 642-653
30. Meleth A.D., Agron E., Chan C.C., Reed G.F., Arora K., Byrnes G., Csaky K.G., Ferris III F.L., and Chew E.Y. Serum inflammatory markers in diabetic retinopathy. Investigative Ophthalmology & Visual Science 46 (2005) 4295-4301
31. Miyamoto K., Khosrof S., Bursell S.E., Rohan R., Murata T., Clermont A.C., Aiello L.P., Ogura Y., and Adamis A.P. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proceedings of the National Academy of Sciences of the United States of America 96 (1999) 10836-10841
32. Miyamoto K., Khosrof S., Bursell S.E., Moromizato Y., Aiello L.P., Ogura Y., and Adamis A.P. Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). American Journal of Pathology 156 (2000) 1733-1739
33. Nishijima K., Kiryu J., Tsujikawa A., Miyamoto K., Honjo M., Tanihara H., Nonaka A., Yamashiro K., Katsuta H., Miyahara S., Honda Y., and Ogura Y. Platelets adhering to the vascular wall mediate postischemic leukocyte-endothelial cell interactions in retinal microcirculation. Investigative Ophthalmology & Visual Science 45 (2004) 977-984
34. Olson J.A., Whitelaw C.M., McHardy K.C., Pearson D.W., and Forrester J.V. Soluble leucocyte adhesion molecules in diabetic retinopathy stimulate retinal capillary endothelial cell migration. Diabetologia 40 (1997) 1166-1171
35. Panès J., Kurose I., Rodriguez-Vaca D., Anderson D.C., Miyasaka M., Tso P., and Granger D.N. Diabetes exacerbates inflammatory responses to ischemia-reperfusion. Circulation 93 (1996) 161-167
36. Shimizu E., Funatsu H., Yamashita H., Yamashita T., and Hori S. Plasma level of interleukin-6 is an indicator for predicting diabetic macular edema. Japanese Journal of Ophthalmology 46 (2002) 78-83
37. Song M., and Kellum J.A. Interleukin-6. Critical Care Medicine 33 (2005) S463-S465
38. Schram M.T., Chaturvedi N., Schalkwijk C.G., Fuller J.H., and Stehouwer C.D. Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes-the EURODIAB Prospective Complications Study. Diabetologia 48 (2005) 370-378
39. Tsujikawa A., Kiryu J., Nonaka A., Yamashiro K., Nishiwaki H., Honda Y., and Ogura Y. Leukocyte-endothelial cell interactions in diabetic retina after transient retinal ischemia. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 279 (2000) R980-R989
40. UKPDS Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352 (1998) 837-853
41. Wellen K.E., and Hotamisligil G.S. Inflammation, stress, and diabetes. Journal of Clinical Investigation 115 (2005) 1111-1119
42. Wilkinson C.P., Ferris III F.L., Klein R.E., Lee P.P., Agardh C.D., Davis M., Dills D., Kampik A., Pararajasegaram R., and Verdaguer J.T. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110 (2003) 1677-1682
43. World Health Organization. Global update of available data on visual impairment, 2006. Available from (2006). http://www.who.int/blindness [Accessed 26 August 2006]
44. Yuuki T., Kanda T., Kimura Y., Kotajima N., Tamura J., Kobayashi T., and Kishi S. Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy. Journal of Diabetes and Its Complications 15 (2001) 157-259